PGP and acute myeloid leukemia: Ginsenoside F1 inhibits P-gp ATPase activity and thereby inhibits P-gp in daunorubicin- and doxorubicin-resistant acute myelogenous leukemia sublines (AML-2/D100 and AML-2/DX100) [213].